Polygenic Multiple Sclerosis Risk
Polygenic Multiple Sclerosis Risk
The Generation R Study Group, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands
Polygenic Multiple Sclerosis Risk and Population-Based Childhood Brain Imaging
https://pubmed.ncbi.nlm.nih.gov/32162725/
Abstract
Objective: Multiple sclerosis (MS) is a neurological disease with a substantial genetic component and immune-mediated neurodegeneration. Patients with MS show structural brain differences relative to individuals without MS, including smaller regional volumes and alterations in white matter (WM) microstructure. Whether genetic risk for MS is associated with brain structure during early neurodevelopment remains unclear. In this study, we explore the association between MS polygenic risk scores (PRS) and brain imaging outcomes from a large, population-based pediatric sample to gain insight into the underlying neurobiology of MS.
Methods: We included 8-to-12 year-old genotyped participants from the Generation R Study in whom T1 -weighted volumetric-(n=1,136) and/or diffusion tensor imaging (n=1,088) had been collected. PRS for MS were calculated based on a large genome-wide association study of MS (n=41,505), and were regressed on regional volumes, global and tract-specific fractional anisotropy (FA) and global mean diffusivity using linear regression.
Results: No associations were observed for the regional volumes. We observed a positive association between the MS-PRS and global FA(β=0.098, standard error (SE)=0.030, p=1.08×10-3 ). Tract-specific analyses showed higher FA and lower radial diffusivity in several tracts. We replicated our findings in an independent sample of children (n=186) who were scanned in an earlier phase (Global FA; β=0.189, SE=0.072, p=9.40×10-3 ).
Interpretation: This is the first study to show that greater genetic predisposition for MS is associated with higher global brain WM FA at an early age in the general population. Our results suggest a pre-adolescent time-window within neurodevelopment in which MS risk variants act upon the brain. This article is protected by copyright. All rights reserved.
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 335 Views
-
Last post by Petr75
Sun Oct 18, 2020 6:20 am
-
- 1 Replies
- 934 Views
-
Last post by Petr75
Sat Nov 02, 2019 9:51 am
-
-
A unified view of multiple sclerosis
by frodo » Sat Jan 30, 2021 3:48 am » in MS Etiology and Pathogenesis - 0 Replies
- 573 Views
-
Last post by frodo
Sat Jan 30, 2021 3:48 am
-
-
-
Biomarker: N-glucosylation in Multiple Sclerosis
by frodo » Tue Jul 21, 2020 1:54 am » in MS Etiology and Pathogenesis - 0 Replies
- 252 Views
-
Last post by frodo
Tue Jul 21, 2020 1:54 am
-
-
-
Multiple Sclerosis and Ischemic Stroke
by Petr75 » Fri Mar 29, 2019 10:23 am » in General Discussion - 0 Replies
- 824 Views
-
Last post by Petr75
Fri Mar 29, 2019 10:23 am
-
-
-
Exercise and the brain in multiple sclerosis
by NHE » Sat Nov 14, 2020 4:31 am » in Exercise and Physical Therapy - 0 Replies
- 313 Views
-
Last post by NHE
Sat Nov 14, 2020 4:31 am
-
-
- 0 Replies
- 413 Views
-
Last post by Petr75
Thu Dec 10, 2020 11:35 am
-
-
Type 1 diabetes (T1D) and multiple sclerosis
by Petr75 » Thu Jan 09, 2020 4:23 am » in General Discussion - 1 Replies
- 675 Views
-
Last post by frodo
Wed Jan 15, 2020 4:02 am
-
-
-
Potential vaccine for multiple sclerosis disease
by Petr75 » Mon May 06, 2019 4:13 am » in General Discussion - 0 Replies
- 439 Views
-
Last post by Petr75
Mon May 06, 2019 4:13 am
-